TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event
Design (Testphase)

Growth

High Revenue Growth

83 Hits
August 3, 2026 last calculated

Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 83 hits from US

Consistently high revenue growth: in each of the last 6 quarters, revenue was at least 20% above the same quarter a year earlier (year-over-year). This filters out stocks that only grew strongly in a single quarter — the goal is steady, fast growth sustained over a year and a half. Requirement: at least 6 quarters of data history.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Stress RS (Strength on Stress Days)
A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
YoY (Year-over-Year)
Year over Year: the quarter is compared with the same quarter of the prior year, not the previous quarter. This removes seasonal effects (holiday shopping, etc.) and is the standard for growth rates.

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns ▾

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

High Revenue Growth
Symbol Earnings Avg/Y 3Y Stress RS Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
AAOI Applied Optoelectronics, Inc. 08/06 +1,099 % 92 10/25 Stage 2 B 62 4 of 9 7.6 $ Communication Equipment Sells AI Technology 94.30 $ +322.9 % +266.1 % +312.4 % −40.7 % +59.4 % 98 42 12.0 % 12.7 % 3.69 84.0 14.9 6.9 0.78 38.4 -8.6 % 29.6 % -8.6 % -6.1 % -3.3 % 0.16 70.6 % +82.8 % 5 0.0 % 0.0 % 7.6 68.3 % 12.9 % 4.2 (5)
CRDO Credo Technology Group Holding Ltd 09/02 +487 % 72 7/25 Stage 2 A 87 7 of 9 38.5 $ Semiconductors Sells AI Technology 207.00 $ +89.0 % +63.6 % +85.6 % −13.2 % +34.9 % 96 93 10.5 % 11.3 % 3.20 83.7 35.1 28.8 18.8 94.6 77.5 35.7 % 68.0 % 35.4 % 34.4 % 17.9 % 0.01 89.9 % +205.7 % 9 0.0 % 0.0 % 19.7 75.9 % 3.6 % 4.6 (13)
TVTX Travere Therapeutics Inc 08/05 +82 % 68 6/22 Stage 2 B 64 5 of 9 5.1 $ Biotechnology Uses AI Healthcare 55.90 $ +46.4 % +44.7 % +261.8 % −1.8 % +5.8 % 96 42 3.6 % 4.6 % 1.11 76.3 9.5 51.5 292.4 136.5 -29.0 % 56.0 % -4.0 % -69.4 % -6.5 % 3.35 17.8 % +110.5 % 6 0.0 % 0.0 % -2.7 113.4 % 16.9 % 4.6 (15)
ELA Envela Corp 08/05 +95 % 94 13/31 Stage 2 A 79 8 of 9 0.6 $ Luxury Goods Neutral Consumer Cyclical 21.70 $ +100.4 % +120.5 % +300.0 % −9.2 % +17.5 % 96 92 6.6 % 6.7 % 0.37 27.2 54.1 1.9 7.4 26.7 18.7 21.5 % 7.2 % 32.0 % 17.5 % 0.26 +33.6 % 5 0.0 % 0.0 % 11.9 19.6 % 4.9 % 5.0 (2)
MTSI MACOM Technology Solutions Holdings, Inc. 08/06 +176 % 95 11/25 Stage 2 B 68 8 of 9 20.4 $ Semiconductors Sells AI Technology 251.40 $ +117.3 % +111.9 % +83.4 % −6.9 % +59.5 % 95 75 6.2 % 6.4 % 1.66 100.8 36.8 19.0 12.8 133.8 2.05 68.4 17.6 % 55.7 % 16.5 % 13.5 % 5.5 % 0.35 70.4 % +32.6 % 7 0.0 % 0.0 % 9.4 99.6 % 3.0 % 4.3 (16)
SITM Sitime Corporation 08/05 +172 % 72 7/25 Stage 2 A 77 7 of 9 15.1 $ Semiconductors Sells AI Technology 535.20 $ +100.1 % +87.9 % +163.8 % −25.1 % +56.5 % 95 12 8.0 % 7.5 % 2.91 71.9 39.6 12.1 278.7 3.82 3,076.2 -4.2 % 55.7 % -6.4 % -2.6 % -2.3 % 0.00 89.6 % +61.2 % 5 0.0 % 0.0 % 16.1 89.0 % 5.0 % 3.9 (7)
IBRX Immunitybio Inc 08/04 +57 % 56 5/22 Stage 2 C 51 3 of 9 7.4 $ Biotechnology Uses AI Healthcare 7.20 $ +269.7 % +309.8 % +191.5 % −37.3 % +77.1 % 94 42 7.8 % 7.0 % 0.08 0.0 52.7 -9.0 -157.9 % 99.3 % 0.0 % 0.0 % -34.4 % -134.5 % +668.3 % 6 0.0 % 0.0 % -23.1 17.6 % 34.6 % 4.6 (5)
RKLB Rocket Lab USA Inc. 08/06 +539 % 66 8/29 Stage 2 B 63 4 of 9 41.7 $ Aerospace & Defense Industrials 65.00 $ +36.4 % +27.0 % +41.4 % −46.6 % +76.1 % 93 42 8.8 % 9.5 % 2.55 0.0 61.4 19.0 -16.4 -22.4 % 36.6 % -26.9 % -13.6 % -6.6 % 0.07 80.3 % +38.0 % 3 0.0 % 0.0 % 9.1 59.0 % 8.0 % 4.1 (15)
OUST Ouster, Inc. Common Stock 08/06 +244 % 61 6/25 Stage 2 B 58 6 of 9 2.6 $ Electronic Components Sells AI Technology 39.00 $ +108.7 % +141.8 % +66.9 % −18.8 % +33.7 % 93 42 15.3 % 13.5 % 3.18 0.0 14.2 -0.8 -39.6 % 47.7 % -30.1 % -25.2 % -14.7 % 72.2 % +52.5 % 5 0.0 % 0.0 % -0.7 50.0 % 9.3 % 4.3 (6)
SEI Solaris Energy Infrastructure, Inc 07/22 +327 % 79 3/10 Stage 2 B 73 5 of 9 5.1 $ Oil & Gas Equipment & Services Sells AI Energy 51.40 $ +70.3 % +76.6 % +59.0 % −7.8 % +83.5 % 92 87 7.0 % 7.1 % 1.18 384.6 7.3 0.94 20.2 25.8 % 46.9 % 6.7 % 8.7 % 5.0 % 26.1 % +98.7 % 5 0.9 % 66.7 % 4.1 113.1 % 26.1 % 4.9 (8)
GH Guardant Health Inc 07/29 +89 % 78 7/22 Stage 2 B 55 6 of 9 21.5 $ Diagnostics & Research Sells AI Healthcare 162.00 $ +28.1 % +50.2 % +295.3 % −2.0 % +15.7 % 92 42 5.3 % 5.7 % 1.59 0.0 18.2 63.1 -5.4 -40.2 % 65.0 % -38.3 % -4,584.5 % -18.1 % -6.60 -9.5 % +32.9 % 3 0.0 % 0.0 % 0.1 106.0 % 9.0 % 4.7 (23)
AXSM Axsome Therapeutics Inc 08/03 +58 % 78 7/22 Stage 2 B 55 5 of 9 11.6 $ Biotechnology Healthcare 218.00 $ +32.5 % +56.9 % +115.0 % −8.8 % +29.5 % 92 42 3.6 % 3.5 % 0.60 333.3 16.3 205.5 -14.8 -32.8 % 92.6 % -26.6 % -349.4 % -16.8 % 4.03 7.6 % +65.6 % 7 0.0 % 0.0 % -3.1 76.6 % 9.2 % 4.7 (19)
ETON Eton Pharmaceuticals Inc 08/06 +249 % 96 10/22 Stage 2 B 55 7 of 9 1.3 $ Drug Manufacturers - Specialty & Generic Healthcare 46.40 $ +98.0 % +116.2 % +227.8 % −2.4 % +18.0 % 92 26 4.8 % 5.7 % 0.86 52.6 14.7 42.5 82.9 206.8 59.7 % -1.7 % -5.4 % 4.8 % 0.40 +104.9 % 8 0.0 % 0.0 % 0.7 65.4 % 6.3 % 4.7 (3)
UMAC Unusual Machines, Inc. 08/13 83 8/25 Stage 2 C 52 3 of 9 1.0 $ Computer Hardware Neutral Technology 21.20 $ +56.4 % +30.8 % +129.0 % −40.4 % +64.4 % 92 42 10.2 % 15.0 % 14.79 67.6 60.9 3.0 0.0 -89.7 % 35.2 % -32.7 % -3.3 % -10.2 % 0.00 95.8 % +101.2 % 1 0.0 % 0.0 % 76.3 60.2 % 19.7 % 4.7 (3)
SEZL Sezzle Inc. 08/06 70 6/22 Stage 2 A 76 6 of 9 5.4 $ Credit Services Uses AI Financial Services 154.80 $ +138.8 % +131.8 % -0.1 % −12.3 % +5.7 % 91 76 8.0 % 7.4 % 6.72 22.2 30.3 11.2 15.9 22.5 0.11 28.5 61.0 % 74.3 % 30.8 % 92.0 % 47.5 % 0.74 43.3 % +66.1 % 9 0.0 % 0.0 % 11.4 40.9 % 23.2 % 5.0 (2)
TGTX TG Therapeutics Inc 08/03 +43 % 53 5/22 Stage 2 B 68 5 of 9 8.0 $ Biotechnology Neutral Healthcare 52.00 $ +80.9 % +79.3 % +46.6 % −6.5 % +31.6 % 90 92 5.0 % 4.8 % 1.60 18.9 55.2 11.5 14.2 1.61 54.6 17.0 % 83.1 % 66.0 % 112.6 % 8.6 % 1.29 38.1 % +87.3 % 6 0.0 % 0.0 % 6.2 70.2 % 29.0 % 4.3 (9)
ATLC Atlanticus Holdings Corporation 08/06 +51 % 41 4/22 Stage 2 B 71 6 of 9 1.6 $ Credit Services Uses AI Financial Services 105.50 $ +51.4 % +49.6 % +112.6 % −2.8 % +19.4 % 90 77 6.3 % 6.0 % 2.12 7.9 1.3 2.0 0.0 72.4 % 21.4 % 21.4 % 2.5 % +53.3 % 7 0.0 % 0.0 % 4.5 25.0 % 25.8 % 4.3 (7)
ASTH Astrana Health Inc 08/06 +13 % 70 6/22 Stage 2 B 62 5 of 9 1.8 $ Medical Care Facilities Uses AI Healthcare 35.60 $ +66.1 % +79.3 % +49.0 % −0.5 % +38.6 % 89 87 3.6 % 3.8 % 0.89 23.0 0.5 11.4 14.4 3.0 % 10.7 % 0.9 % 5.7 % 3.6 % 33.9 % +56.4 % 5 0.0 % 0.0 % 5.2 61.5 % 10.3 % 4.5 (12)
NUVB Nuvation Bio Inc 08/06 +81 % 69 6/22 Stage 2 B 67 6 of 9 2.1 $ Biotechnology Healthcare 6.30 $ -32.6 % -41.1 % +168.2 % −40.4 % +102.8 % 89 42 7.2 % 7.6 % 1.53 0.0 14.7 7.6 2.2 4.7 % 90.8 % -102.1 % -39.5 % -17.0 % 0.03 52.4 % +699.0 % 5 0.0 % 0.0 % 2.5 64.9 % 26.5 % 4.6 (7)
NAVN Navan, Inc. Class A Common Stock Stage 2 B 59 5 of 9 0.0 $ Software - Application Technology 26.60 $ +24.6 % +49.7 % −11.9 % +36.2 % 89 50 7.0 % 7.2 % 114.9 4.6 0.0 72.2 % -46.7 % -52.9 % -8.4 % 0.14 +30.8 % 5 0.0 % 0.0 % 4.7 60.1 % 19.0 %
AMPX Amprius Technologies Inc. 08/06 +25 % 90 11/29 Stage 1 B 61 5 of 9 1.4 $ Electrical Equipment & Parts Neutral Industrials 9.60 $ +79.0 % +58.5 % +38.5 % −48.2 % +139.6 % 87 42 8.7 % 9.8 % 2.26 0.0 15.1 12.8 -34.5 -23.4 % 18.1 % -44.0 % -44.2 % -10.6 % 0.06 83.7 % +202.1 % 5 0.0 % 0.0 % 5.9 65.2 % 20.1 % 4.4 (7)
ECOR Electrocore LLC 08/05 +35 % 70 6/22 Stage 2 C 45 4 of 9 0.1 $ Medical Devices Healthcare 6.10 $ +86.2 % +66.4 % -12.1 % −31.5 % +166.6 % 87 42 11.0 % 11.5 % 0.89 384.6 1.5 29.6 0.2 87.3 % -44.1 % -478.7 % -58.1 % -1.67 +27.2 % 0.0 % 0.0 % -44.7 9.2 % 2.6 %
MIRM Mirum Pharmaceuticals Inc 08/05 +102 % 68 6/22 Stage 2 C 45 3 of 9 6.3 $ Biotechnology Healthcare 106.00 $ +40.6 % +52.3 % +105.0 % −1.9 % +38.2 % 86 42 5.0 % 5.0 % 0.49 39.7 11.0 28.1 341.2 -39.5 % 81.4 % -140.2 % -335.8 % -5.9 % 1.34 27.2 % +54.7 % 7 0.0 % 0.0 % -5.4 114.4 % 15.6 % 4.6 (10)
FTAI FTAI Aviation Ltd. 08/04 +283 % 76 9/29 Stage 2 B 68 5 of 9 21.0 $ Aerospace & Defense Industrials 206.00 $ +33.6 % +52.7 % +50.9 % −17.0 % +82.8 % 83 77 6.6 % 6.4 % 1.51 41.0 28.5 6.8 49.0 3.22 22.2 22.5 % 32.2 % 15.9 % 233.3 % 11.4 % 10.23 9.5 % +43.2 % 5 1.0 % 34.1 % 8.0 97.2 % 10.6 % 4.5 (13)
DAVE Dave Inc 08/05 +2,117 % 61 6/25 Stage 2 A 84 6 of 9 4.7 $ Software - Application Uses AI Technology 372.70 $ +43.6 % +62.5 % +58.1 % −5.8 % +4.5 % 83 86 8.5 % 8.1 % 3.83 22.7 7.8 14.4 22.1 38.3 % 72.1 % 37.2 % 111.6 % 32.0 % 38.4 % +59.7 % 9 0.0 % 0.0 % 11.6 100.1 % 21.0 % 4.8 (8)
PSTL Postal Realty Trust Inc 08/03 +33 % 75 6/21 Stage 2 B 62 6 of 9 0.8 $ REIT - Office Real Estate 23.00 $ +48.7 % +60.3 % +75.0 % −0.6 % +10.1 % 82 83 3.1 % 2.7 % 0.79 45.2 45.2 8.0 2.2 21.6 17.7 78.3 % 15.8 % 5.9 % 3.1 % 1.40 +25.5 % 7 4.3 % 1.6 % 3.6 82.9 % 4.4 % 4.1 (8)
AEVA Aeva Technologies, Inc. 07/30 +100 % 80 8/25 Stage 2 C 50 5 of 9 1.3 $ Software - Infrastructure Technology 17.50 $ +77.3 % +90.3 % -5.9 % −48.1 % +43.6 % 81 42 12.5 % 12.1 % 2.40 0.0 60.6 68.6 -0.1 4.6 % 0.0 % -516.1 % -63.2 % -8.22 +99.4 % 5 0.0 % 0.0 % -16.8 66.1 % 10.2 % 4.4 (5)
WLFC Willis Lease Finance Corporation 08/04 +149 % 59 7/29 Stage 2 B 63 6 of 9 1.7 $ Rental & Leasing Services Neutral Industrials 71.30 $ +55.8 % +65.6 % +52.4 % −7.1 % +5.7 % 80 77 4.7 % 4.4 % 0.72 6.9 2.2 0.94 9.3 83.7 % 16.2 % 17.6 % 5.1 % +18.7 % 5 0.8 % 12.6 % 5.2 47.3 % 16.1 % 5.0 (1)
PRE Prenetics Global Ltd +16 % 91 6/16 Stage 2 B 60 5 of 9 0.3 $ Packaged Foods Uses AI Consumer Defensive 18.60 $ +26.5 % +9.9 % +131.0 % −16.4 % +57.0 % 80 42 6.2 % 8.5 % 0.25 0.0 2.8 2.6 11.4 55.4 % -42.0 % -40.8 % -13.5 % 0.00 +201.7 % 0.0 % 0.0 % 12.8 % 4.2 %
ARQT Arcutis Biotherapeutics Inc 08/05 +66 % 54 5/22 Stage 3 B 65 6 of 9 3.4 $ Biotechnology Healthcare 26.90 $ -9.5 % -9.1 % +84.2 % −16.0 % +28.7 % 77 42 4.7 % 4.6 % 1.48 149.3 8.2 17.9 127.3 226.7 -8.6 % 90.9 % -0.6 % -1.4 % 0.5 % 0.07 41.2 % +91.3 % 6 0.0 % 0.0 % -0.1 110.2 % 11.6 % 4.6 (7)
GKOS Glaukos Corp 07/29 +33 % 68 6/22 Stage 2 B 56 3 of 9 9.7 $ Medical Devices Healthcare 166.70 $ +19.3 % +21.9 % +93.7 % −3.7 % +16.1 % 76 98 3.9 % 5.6 % 0.75 2,000.0 15.9 14.6 1.64 -57.9 -13.2 % 79.1 % -30.7 % -26.4 % -5.2 % 0.15 75.1 % +32.3 % 5 0.0 % 0.0 % 4.4 102.1 % 9.7 % 4.3 (15)
ABX Abacus Global Management, Inc. 08/06 -1 % 89 8/22 Stage 2 B 69 8 of 9 1.0 $ Insurance - Life Financial Services 10.30 $ +12.6 % +26.2 % +96.4 % −12.3 % +36.7 % 76 76 4.9 % 4.7 % 0.06 28.0 10.6 4.0 2.4 7.9 11.5 88.8 % 15.6 % 9.1 % 7.3 % 0.81 +110.2 % 5 1.9 % 31.8 % 5.6 28.5 % 20.7 %
CURB Curbline Properties Corp. 07/27 31 3/21 Stage 2 B 59 4 of 9 3.2 $ REIT - Retail Real Estate 30.60 $ +35.2 % +36.1 % +42.5 % −0.7 % +8.9 % 75 9 2.2 % 2.3 % 50.5 15.7 26.3 26.5 13.1 % 75.2 % 13.1 % 1.7 % 1.0 % 72.3 % +51.3 % 8 2.2 % 130.2 % 6.8 119.7 % 29.5 % 3.4 (9)
ALHC Alignment Healthcare LLC 07/29 +85 % 68 6/22 Stage 3 B 72 7 of 9 3.0 $ Healthcare Plans Uses AI Healthcare 14.90 $ +9.7 % +21.5 % +7.8 % −4.9 % +65.2 % 72 42 4.6 % 5.7 % 1.05 142.3 204.1 0.7 14.2 16.1 31.3 1.3 % 12.6 % 0.9 % 12.5 % 3.1 % 1.60 16.4 % +46.1 % 8 0.0 % 0.0 % 3.3 106.7 % 12.3 % 4.1 (11)
IDR Idaho Strategic Resources Inc 08/06 +168 % Stage 1 A 77 7 of 9 0.0 $ Gold Neutral Basic Materials 28.10 $ -18.9 % -31.5 % +71.2 % −40.5 % +38.3 % 72 50 8.4 % 8.0 % 1.21 23.3 22.0 4.5 18.9 69.7 % 43.3 % 26.5 % 15.7 % 0.02 +64.6 % 7 0.0 % 0.0 % 25.9 46.7 % 8.0 %
RYTM Rhythm Pharmaceuticals Inc 08/04 +170 % 39 4/22 Stage 3 B 57 5 of 9 6.7 $ Biotechnology Healthcare 99.30 $ -0.8 % -2.0 % +16.5 % −11.4 % +39.8 % 70 42 5.8 % 4.8 % 1.88 0.0 31.0 55.4 -12.6 -87.1 % 89.4 % -93.3 % -101.2 % -29.8 % 1.85 27.8 % +45.8 % 5 0.0 % 0.0 % -4.6 110.0 % 14.1 % 4.7 (12)
AMSC American Superconductor Corporation 07/29 +203 % 60 7/29 Stage 3 A 79 6 of 9 1.6 $ Specialty Industrial Machinery Neutral Industrials 29.40 $ +44.6 % +27.1 % -48.3 % −42.9 % +112.6 % 66 91 7.0 % 7.9 % 3.22 28.3 5.2 84.9 0.74 53.4 5.1 % 30.8 % 44.7 % 35.6 % 2.1 % 75.1 % +34.3 % 5 0.0 % 0.0 % 4.2 69.8 % 7.3 % 4.7 (3)
XERS Xeris Pharmaceuticals Inc 08/06 +49 % 39 4/22 Stage 3 B 73 8 of 9 1.4 $ Drug Manufacturers - Specialty & Generic Healthcare 8.10 $ -8.3 % +7.4 % +58.7 % −26.6 % +39.3 % 66 42 3.5 % 4.0 % 0.85 101.0 4.4 29.5 28.9 9.5 % 85.9 % 3.8 % -617.2 % 6.3 % 3.3 % +43.7 % 8 0.0 % 0.0 % 0.5 62.4 % 6.0 % 4.5 (6)
NTRA Natera Inc 08/06 +119 % 52 5/22 Stage 2 B 57 5 of 9 38.6 $ Diagnostics & Research Healthcare 267.80 $ +2.5 % +15.6 % +100.3 % −3.9 % +5.6 % 64 42 6.1 % 5.4 % 1.51 0.0 15.4 21.6 419.2 -26.8 -12.4 % 65.1 % -9.0 % -15.0 % -9.1 % 0.15 67.9 % +35.9 % 6 0.0 % 0.0 % 3.9 95.8 % 3.6 % 4.5 (21)
AFRM Affirm Holdings Inc 08/27 +128 % 53 5/22 Stage 3 A 79 8 of 9 24.1 $ Credit Services Uses AI Financial Services 71.50 $ -3.5 % +7.6 % +4.3 % −23.2 % +26.7 % 63 98 6.5 % 6.1 % 3.67 65.7 36.4 6.1 6.4 30.6 0.72 27.4 8.5 % 48.4 % 9.6 % 11.5 % 1.7 % 2.74 28.8 % +38.8 % 6 0.0 % 0.0 % 9.1 86.9 % 5.7 % 4.2 (24)
PNTG Pennant Group Inc 08/05 +60 % 88 8/22 Stage 2 B 56 2 of 9 1.4 $ Medical Care Facilities Healthcare 40.30 $ +21.6 % +24.3 % +81.9 % −4.5 % +11.7 % 63 58 4.2 % 4.5 % 1.25 46.9 30.2 1.3 4.0 29.1 2.32 28.0 19.6 % 3.0 % 10.0 % 4.1 % 1.31 +36.3 % 3 0.0 % 0.0 % 4.7 95.1 % 2.2 % 3.8 (4)
OMDA Omada Health, Inc. Common Stock 08/06 Stage 3 B 65 3 of 9 0.0 $ Health Information Services Healthcare 19.80 $ +16.0 % +36.1 % +13.2 % −29.8 % +21.3 % 61 50 5.3 % 5.1 % 769.2 4.6 1,364.4 66.3 % -2.2 % -4.3 % -2.4 % +53.2 % 8 0.0 % 0.0 % 6.1 81.6 % 13.4 %
BROS Dutch Bros Inc 08/05 +47 % 42 6/31 Stage 2 B 70 4 of 9 11.6 $ Restaurants Consumer Cyclical 65.80 $ +10.2 % +11.8 % +11.1 % −10.8 % +21.7 % 56 31 5.2 % 5.1 % 2.32 104.0 68.5 6.6 13.1 127.8 2.36 33.8 7.7 % 25.3 % 4.6 % 13.8 % 3.7 % 1.67 22.4 % +27.9 % 5 0.0 % 0.0 % 4.2 98.6 % 34.7 % 4.7 (24)
RBRK Rubrik, Inc. 72 7/25 Stage 3 B 65 5 of 9 14.6 $ Software - Infrastructure Sells AI Technology 72.40 $ -2.9 % +12.5 % -23.8 % −17.5 % +31.5 % 54 42 5.8 % 6.2 % 1.10 434.8 10.2 0.0 48.4 0.0 -13.6 % 80.6 % -20.3 % 0.0 % -9.0 % -2.38 -18.8 % +48.5 % 5 0.0 % 0.0 % 1.6 76.9 % 8.6 % 4.9 (29)
HALO Halozyme Therapeutics Inc 08/04 +35 % 88 8/22 Stage 2 B 66 6 of 9 9.7 $ Biotechnology Healthcare 82.50 $ +3.4 % +12.8 % +37.6 % −11.7 % +5.3 % 48 71 3.6 % 3.2 % 0.84 29.9 11.4 6.4 46.0 14.5 18.6 49.0 % 76.7 % 23.1 % 99.4 % 22.1 % 9.77 8.2 % +37.6 % 8 0.0 % 0.0 % 6.5 107.2 % 14.5 % 3.6 (8)
ANIP ANI Pharmaceuticals Inc 08/14 +20 % 80 7/22 Stage 3 B 68 8 of 9 1.8 $ Drug Manufacturers - Specialty & Generic Healthcare 79.20 $ +5.1 % +2.4 % +25.1 % −16.3 % +38.9 % 44 84 3.1 % 3.1 % 0.43 20.2 8.9 2.0 3.2 11.3 1.06 9.3 16.3 % 60.8 % 10.0 % 18.3 % 5.0 % 0.58 39.5 % +43.8 % 7 0.0 % 0.0 % 7.0 110.4 % 18.1 % 4.3 (6)
CBLL CeriBell, Inc 08/04 Stage 1 C 49 2 of 9 0.0 $ Medical Devices Healthcare 17.70 $ -16.1 % -6.8 % +22.9 % −18.9 % +36.1 % 43 50 4.9 % 4.4 % 0.0 5.3 0.0 87.7 % -63.5 % -37.5 % -20.7 % 0.16 +36.1 % 6 0.0 % 0.0 % 6.2 86.8 % 8.2 %
BOW Bowhead Specialty Holdings Inc. 08/04 Stage 2 B 69 6 of 9 0.0 $ Insurance - Property & Casualty Financial Services 30.60 $ -1.1 % +4.7 % -5.9 % −25.6 % +11.2 % 42 50 3.9 % 4.0 % -0.11 16.0 14.9 2.0 0.0 32.1 % 10.0 % 13.7 % 2.5 % 0.32 +29.6 % 8 0.0 % 0.0 % 8.3 93.9 % 4.3 %
KMTS Kestra Medical Technologies, Ltd. 56 5/22 Stage 4 B 56 5 of 9 1.3 $ Medical Instruments & Supplies Healthcare 22.80 $ -22.0 % -7.9 % +38.4 % −24.7 % +31.6 % 36 42 8.1 % 7.3 % 0.0 13.4 4.6 0.0 51.4 % -138.4 % -92.7 % -25.8 % 0.02 +115.1 % 5 0.0 % 0.0 % 3.6 102.9 % 10.0 % 4.5 (6)
SKYH Sky Harbour Group Corporation 08/11 +34 % 31 3/21 Stage 3 B 65 5 of 9 0.8 $ Real Estate - Development Real Estate 10.70 $ +6.1 % +6.3 % +9.5 % −17.4 % +52.6 % 33 90 3.2 % 3.9 % 1.31 12.4 26.7 54.8 -46.6 % 63.9 % 4.7 % -2.7 % +86.6 % 4 0.0 % 0.0 % 3.3 38.4 % 13.4 % 4.5 (6)
SLDE Slide Insurance Holdings, Inc. Common Stock 08/11 Stage 1 B 62 7 of 9 0.0 $ Insurance - Property & Casualty Financial Services 20.00 $ -10.3 % +1.0 % +6.2 % −20.2 % +39.5 % 32 50 4.5 % 3.7 % 0.0 0.0 47.9 % 66.9 % 38.9 % 59.7 % 17.0 % 38.6 % +36.5 % 8 0.0 % 0.0 % 7.3 47.7 % 8.5 %
RDDT Reddit, Inc. 07/30 83 8/24 Stage 4 A 89 8 of 9 28.6 $ Internet Content & Information Sells AI Communication Services 140.70 $ -27.9 % -22.8 % -12.4 % −44.2 % +55.1 % 31 96 6.8 % 6.8 % 1.94 40.3 31.0 10.3 8.5 28.1 1.01 30.3 27.6 % 91.4 % 31.4 % 26.2 % 15.7 % 0.01 91.3 % +69.4 % 8 0.0 % 0.0 % 21.0 93.6 % 12.1 % 3.9 (26)
VEL Velocity Financial Llc 08/06 +14 % 40 4/22 Stage 4 B 66 4 of 9 0.7 $ Mortgage Finance Financial Services 17.50 $ -14.9 % -7.9 % +5.7 % −17.0 % +24.8 % 30 59 2.5 % 2.6 % 0.70 6.4 0.0 1.0 1.0 25.6 0.0 74.9 % 40.0 % 17.2 % 1.6 % 9.70 +48.0 % 5 0.0 % 0.0 % 3.7 98.9 % 29.7 % 3.3 (3)
S SentinelOne Inc 08/27 -1 % 73 7/25 Stage 3 B 58 5 of 9 6.4 $ Software - Infrastructure Technology 19.10 $ +0.9 % +12.7 % +3.9 % −30.1 % +3.0 % 29 42 4.8 % 5.3 % 0.83 56.2 6.1 4.6 143.6 -11.0 -28.8 % 73.3 % -30.4 % -21.4 % -7.9 % 61.0 % +21.9 % 6 0.0 % 0.0 % 1.9 84.6 % 6.4 % 4.4 (36)
PHAT Phathom Pharmaceuticals Inc 08/06 -19 % 81 7/22 Stage 4 B 70 5 of 9 0.7 $ Biotechnology Healthcare 8.80 $ -34.5 % -38.4 % +2.5 % −43.5 % +148.9 % 28 42 5.8 % 6.2 % 0.49 0.0 2.9 21.6 -2.2 82.9 % -41.3 % -3,489.0 % -8.8 % -0.49 +216.9 % 4 0.0 % 0.0 % -12.2 89.2 % 16.0 % 4.6 (9)
LMND Lemonade Inc 08/04 +81 % 39 4/22 Stage 4 B 64 4 of 9 3.7 $ Insurance - Property & Casualty Financial Services 48.30 $ -18.7 % -22.1 % +28.2 % −44.0 % +26.8 % 27 42 6.2 % 6.3 % 1.79 0.0 4.5 189.2 0.0 -11.0 % 51.7 % -14.2 % -26.1 % -3.5 % 26.5 % +40.2 % 5 0.0 % 0.0 % 0.9 59.7 % 14.5 % 2.4 (9)
SUNS Sunrise Realty Trust, Inc. 08/06 Stage 4 B 58 4 of 9 0.0 $ REIT - Mortgage Real Estate 7.80 $ -7.0 % -8.5 % -10.5 % −27.1 % +29.5 % 27 50 3.4 % 3.3 % 7.1 0.65 18.5 100.0 % 59.7 % 7.2 % 4.7 % +148.1 % 5 14.7 % 117.7 % 8.0 33.9 % 7.2 %
CARL Carlsmed, Inc. Common Stock 41 4/22 Stage 4 C 51 5 of 9 0.4 $ Health Information Services Healthcare 12.60 $ -13.4 % -19.5 % -10.5 % −34.6 % +47.6 % 26 42 7.7 % 7.2 % 0.0 6.5 3.7 0.0 75.9 % -57.8 % -52.4 % -24.2 % 0.19 +85.9 % 0.0 % 0.0 % 8.1 39.7 % 13.4 %
PLMR Palomar Holdings Inc 08/03 +31 % 88 8/22 Stage 4 B 66 6 of 9 3.6 $ Insurance - Property & Casualty Financial Services 133.80 $ -13.9 % -7.1 % +1.0 % −27.0 % +22.6 % 24 42 3.9 % 3.9 % 0.41 20.0 0.0 3.6 4.0 9.8 0.0 20.3 % 28.7 % 20.1 % 22.5 % 5.3 % 0.31 26.6 % +58.2 % 8 0.0 % 0.0 % 6.5 100.6 % 5.1 % 4.1 (8)
LPLA LPL Financial Holdings Inc 07/30 +15 % 88 8/22 Stage 4 B 61 4 of 9 28.5 $ Capital Markets Financial Services 353.70 $ -17.2 % -27.7 % -10.3 % −31.3 % +21.1 % 22 54 3.6 % 3.9 % 0.51 30.9 14.2 1.6 4.8 0.53 13.9 11.1 % 29.9 % 5.2 % 20.5 % 5.4 % 2.61 30.2 % +37.2 % 5 0.3 % 5.5 % 7.3 105.8 % 6.1 % 4.2 (15)
BULL Webull Corp 08/13 -29 % Stage 4 C 46 1 of 9 0.0 $ Software - Application Technology 7.10 $ -14.5 % -19.5 % -50.3 % −64.5 % +84.3 % 22 50 6.4 % 6.7 % 0.55 37.7 3.2 109.9 -1.5 % 76.3 % -1.7 % -1.3 % -0.4 % 0.08 27.4 % +46.3 % 8 0.0 % 0.0 % 3.4 51.2 % 4.9 %
GRND Grindr Inc 08/06 +45 % 87 9/25 Stage 3 A 75 7 of 9 3.1 $ Software - Application Uses AI Technology 17.30 $ -3.0 % +5.9 % -0.8 % −41.0 % +8.7 % 22 80 5.4 % 4.8 % 0.22 39.8 0.0 6.5 3,875.5 21.2 23.1 74.7 % 19.9 % 58.9 % 16.3 % 23.84 +27.6 % 8 0.0 % 0.0 % 5.0 21.4 % 18.2 % 4.3 (4)
GTLB Gitlab Inc 09/02 -15 % 46 5/25 Stage 4 B 59 6 of 9 5.7 $ Software - Infrastructure Technology 34.50 $ -28.1 % -20.4 % -21.2 % −47.5 % -1.1 % 20 42 5.4 % 6.2 % 0.96 42.0 5.7 6.1 21.8 -32.5 -6.0 % 86.8 % -2.5 % -3.0 % -2.0 % 57.8 % +25.8 % 6 0.0 % 0.0 % 6.2 86.3 % 11.5 % 4.5 (28)
BBNX Beta Bionics, Inc. Common Stock 08/04 Stage 4 D 44 3 of 9 0.0 $ Medical Devices Healthcare 12.80 $ -55.1 % -45.3 % -23.6 % −51.4 % +20.6 % 20 50 7.8 % 7.6 % 0.0 2.1 0.0 57.2 % -60.3 % -22.7 % -15.0 % 0.03 +53.9 % 5 0.0 % 0.0 % 11.0 112.6 % 10.5 %
IOT Samsara Inc 09/03 +7 % 45 5/25 Stage 4 A 75 8 of 9 21.6 $ Software - Infrastructure Sells AI Technology 37.30 $ -11.7 % -12.2 % -2.0 % −39.0 % +18.8 % 19 42 5.7 % 6.6 % 1.35 400.8 52.4 12.5 15.5 92.1 1,426.6 1.5 % 76.3 % 3.3 % 4.4 % -0.3 % 0.05 57.7 % +29.6 % 7 0.0 % 0.0 % 4.3 102.6 % 12.6 % 4.0 (21)
EVLV Evolv Technologies Holdings Inc 08/13 -2 % 85 10/29 Stage 4 C 47 3 of 9 1.0 $ Security & Protection Services Industrials 5.50 $ -22.6 % -15.8 % -15.6 % −41.3 % +84.1 % 19 42 4.8 % 4.8 % 1.77 43.3 6.2 8.6 -5.1 49.8 % -22.8 % -30.2 % -5.8 % 0.35 +40.5 % 6 0.0 % 0.0 % -0.5 72.9 % 5.2 % 4.5 (4)
LIF Life360, Inc. Common Stock 08/10 61 6/25 Stage 4 B 71 4 of 9 4.5 $ Software - Application Technology 54.10 $ -26.8 % -13.5 % -29.4 % −56.5 % +18.7 % 18 17 7.1 % 5.9 % 1.11 33.5 84.7 8.5 7.9 52.1 169.6 77.1 % 28.2 % 30.7 % 0.7 % 0.52 +31.8 % 8 0.0 % 0.0 % 7.4 53.3 % 13.0 % 4.9 (7)
DOMH Dominari Holdings Inc. 08/10 -21 % 57 5/22 Stage 4 D 34 5 of 9 0.1 $ Capital Markets Financial Services 2.50 $ -26.9 % -17.3 % -30.8 % −66.4 % +467.4 % 18 42 8.1 % 7.8 % 0.83 0.0 0.4 1.9 1.7 100.0 % -31.2 % -122.5 % -65.8 % 0.09 +578.4 % 4.2 % 0.0 % -2.2 8.8 % 4.2 %
GNSS Genasys Inc 08/13 -13 % 62 6/25 Stage 4 B 62 6 of 9 0.1 $ Scientific & Technical Instruments Technology 1.70 $ -23.1 % -20.3 % +3.7 % −39.3 % +194.7 % 18 3 5.6 % 5.5 % 0.73 12.7 1.2 26.3 128.6 45.9 % -13.4 % -144.2 % -6.3 % 5.74 +69.8 % 0.0 % 0.0 % -5.6 58.0 % 2.0 %
DUOL Duolingo Inc 08/05 -2 % 79 8/25 Stage 3 A 77 4 of 9 6.0 $ Software - Application Sells AI Technology 134.80 $ -24.7 % -35.8 % -61.1 % −74.4 % -14.8 % 16 68 6.5 % 6.5 % 0.88 16.1 20.0 5.5 5.0 14.5 29.9 15.4 % 72.7 % 38.4 % 37.0 % 5.9 % 0.07 67.6 % +38.7 % 7 0.0 % 0.0 % 9.6 98.5 % 21.4 % 3.9 (23)
GENI Genius Sports Ltd 08/05 0 % 50 5/24 Stage 4 C 46 1 of 9 1.9 $ Internet Content & Information Communication Services 6.90 $ -46.8 % -41.1 % -38.4 % −60.4 % +47.8 % 16 42 7.2 % 7.8 % 1.90 56.8 2.6 2.8 1,440.8 152.7 -15.8 % 22.7 % -22.3 % -22.6 % -10.1 % 0.04 68.3 % +31.0 % 6 0.0 % 0.0 % 1.3 90.7 % 13.5 % 4.7 (15)
ASST Strive Asset Management 08/04 -33 % 55 5/22 Stage 4 D 40 3 of 9 1.0 $ Asset Management Financial Services 11.10 $ -5.5 % -32.6 % -83.3 % −42.3 % +161.3 % 12 42 9.8 % 9.0 % 13.21 0.9 131.9 1.3 -2.3 -535.7 % 0.0 % -125.4 % -62.6 % 0.01 +57.1 % 4 0.0 % 0.0 % 44.2 47.7 % 30.4 %
GEVO Gevo Inc 08/10 +2 % 76 7/23 Stage 4 B 58 4 of 9 0.4 $ Specialty Chemicals Basic Materials 1.50 $ -30.0 % -31.9 % +13.9 % −52.9 % +259.2 % 11 42 6.7 % 5.6 % 1.02 0.0 2.2 28.9 45.8 % -19.4 % -6.9 % -0.8 % +849.3 % 0.0 % 0.0 % 2.1 37.2 % 11.4 % 3.3 (3)
AXON Axon Enterprise Inc. 08/03 +43 % 66 8/29 Stage 4 B 56 5 of 9 42.8 $ Aerospace & Defense Industrials 527.80 $ -23.8 % -13.6 % -30.1 % −49.8 % +25.2 % 10 84 6.8 % 6.5 % 1.38 217.8 66.7 14.4 12.0 2,197.0 4.17 136.4 3.8 % 59.5 % 6.9 % 6.8 % 0.1 % 1.12 50.0 % +33.5 % 5 0.0 % 0.0 % 6.5 88.7 % 5.5 % 4.2 (17)
RBLX Roblox Corp 07/30 +8 % 83 8/24 Stage 4 B 59 6 of 9 25.6 $ Electronic Gaming & Multimedia Communication Services 35.60 $ -41.9 % -33.6 % -74.2 % −69.2 % +57.5 % 6 42 8.4 % 6.6 % 1.41 192.3 4.5 61.0 14.5 8.18 -24.8 -16.4 % 25.7 % -17.6 % -311.9 % -7.7 % 2.16 4.4 % +35.8 % 7 0.0 % 0.0 % 0.4 83.0 % 4.5 % 4.1 (35)
ZS Zscaler Inc 09/02 -4 % 72 7/25 Stage 4 C 50 3 of 9 24.4 $ Software - Infrastructure Technology 151.20 $ -43.9 % -40.1 % -47.1 % −63.3 % +27.4 % 6 42 5.0 % 7.0 % 0.96 32.9 7.7 11.0 25.5 1.65 158.1 -3.3 % 76.7 % -2.4 % -3.7 % -1.4 % 0.79 33.3 % +23.3 % 7 0.0 % 0.0 % 5.2 58.0 % 7.7 % 4.2 (46)
TMDX TransMedics Group Inc 07/29 -3 % 81 7/22 Stage 4 B 66 5 of 9 2.6 $ Medical Devices Healthcare 76.50 $ -39.3 % -47.0 % -35.7 % −50.2 % +43.3 % 6 8 6.6 % 6.1 % 1.88 15.4 41.0 4.2 4.7 17.5 21.8 7.6 % 59.1 % 27.0 % 45.2 % 5.2 % 1.75 34.4 % +37.1 % 7 0.0 % 0.0 % 6.1 108.9 % 34.8 % 4.2 (9)
GWRE Guidewire Software Inc 09/03 +19 % 72 7/25 Stage 4 B 58 3 of 9 11.8 $ Software - Application Technology 151.90 $ -45.5 % -41.3 % -32.8 % −59.6 % +30.6 % 5 10 5.9 % 6.5 % 0.95 90.1 36.4 8.3 10.6 46.5 0.83 63.1 8.2 % 64.0 % 11.3 % 11.9 % 2.9 % 0.79 52.0 % +22.6 % 8 0.0 % 0.0 % 5.6 104.8 % 6.9 % 3.9 (16)
BTCS BTCS Inc 08/12 -20 % 41 4/22 Stage 4 E 23 3 of 9 0.1 $ Capital Markets Financial Services 1.00 $ -59.5 % -64.1 % -77.2 % −88.1 % +395.0 % 3 9 10.1 % 8.6 % 3.39 55.9 3.3 0.7 0.0 17.1 % 0.0 % -184.0 % -5.7 % 0.78 +304.9 % 4.5 % 3.1 % -1.6 22.0 % 6.5 %
LCID Lucid Group Inc 08/04 -30 % 33 5/31 Stage 4 D 44 1 of 9 2.9 $ Auto Manufacturers Consumer Cyclical 7.40 $ -50.9 % -44.9 % -70.0 % −79.7 % +12.2 % 2 42 8.0 % 7.4 % 0.83 0.0 2.1 4.6 -2.1 -95.6 % -239.8 % -97.6 % -28.2 % 1.55 +67.6 % 5 0.0 % 0.0 % -6.5 61.9 % 40.3 % 2.9 (15)
FEMY Femasys Inc 08/14 -33 % 57 5/22 Stage 4 B 60 7 of 9 0.0 $ Medical Instruments & Supplies Healthcare 2.90 $ -65.2 % -74.3 % -82.8 % −42.7 % +1,659.3 % 2 42 9.7 % 11.2 % -2.13 0.0 3.5 1.2 0.2 61.6 % 0.0 % -256.0 % -68.7 % 0.65 +40.8 % 4 0.0 % 0.0 % -25.1 10.1 % 6.9 %
CSAI Cloudastructure, Inc. Class A Common Stock 35 4/25 Stage 4 C 45 5 of 9 0.2 $ Software - Infrastructure Technology 5.80 $ -63.9 % -69.6 % -89.9 % −88.7 % +1,328.6 % 1 42 19.8 % 14.8 % 0.0 36.3 0.0 29.4 % -167.0 % -201.3 % -94.9 % +271.4 % 5 0.0 % 0.0 % -5.5 6.0 % 2.1 %
NBIS Nebius Group N.V. B 59 42.0 $ Internet Content & Information Communication Services 190.40 $ +249.8 % +35.6 % 1.40 68.5 47.8 7.4 0.63 32.1 72.1 % 93.1 % -3.0 % 5 0.0 % 0.0 % 28.0 % 4.7 (3)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Consistently high revenue growth: in each of the last 6 quarters, revenue was at least 20% above the same quarter a year earlier (year-over-year). This filters out stocks that only grew strongly in a single quarter — the goal is steady, fast growth sustained over a year and a half. Requirement: at least 6 quarters of data history.

All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 83 stocks pass this scanner's criteria (as of 3. August 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?